Zicla 60mg/500mg Tablet SR
Marketer
Sinsan Pharmaceuticals
Salt Composition
Gliclazide (60mg) + Metformin (500mg)
Primary Ingredients of Zicla 60mg/500mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Major Benefits of Zicla 60mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length. Ingest the medication whole; do not attempt to chew, crush, or fracture the tablet.
Common Side effects of Zicla 60mg/500mg Tablet SR:
- Acute toxicity
- Nausea
How to use Zicla 60mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length. Ingest the medication whole; avoid chewing, crushing, or breaking the tablet.
How Zicla 60mg/500mg Tablet SR works:
This dual-action medication combines a sulfonylurea with a biguanide to manage type 2 diabetes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Zicla 60mg/500mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Zicla 60mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Zicla 60mg/500mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Zicla 60mg/500mg SR tablets, as dose modification may be necessary. Zicla 60mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Medical supervision, including regular kidney function assessments, is recommended during treatment with this medication.
LiverCAUTION
The extended-release Zicla 60mg/500mg tablet requires careful administration in individuals with hepatic impairment. Dosage modification of Zicla 60mg/500mg extended-release tablets may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, Zicla 60mg/500mg extended-release tablets are typically initiated at a reduced dosage; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Zicla 60mg/500mg Tablet SR :
NA
Facts to Know About Zicla 60mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently